Glucosidase beta 2 pseudogene

The glucosidase beta 2 pseudogene (ENSG00000254131) is a non-protein-coding genomic region annotated as a pseudogene with high sequence similarity to the functional beta-glucosidase protein-coding enzyme genes, but it lacks the ability to produce an active protein. Pseudogenes generally arise from gene duplication or retrotransposition, and acquire mutations or deletions rendering them nonfunctional. While functional beta-glucosidase enzymes (such as those encoded by GBA, GBA2) catalyze key reactions in glycolipid metabolism and are therapeutic targets in diseases like Gaucher disease and hereditary spastic paraplegia[1][2][8], the beta 2 pseudogene does not participate in these functions and is not considered a target in research, pharmacology, or clinical diagnostics[4][7]. There is confusion in the literature because gene names for functional enzymes (GBA, GBA2) are very similar to their pseudogenes (GBAP1, and related annotations). However, only the functional genes produce active enzymes with major roles in metabolism and disease; their pseudogenes are non-coding and non-functional[4][7][8]. If the intention was to obtain information about Glucosylceramidase beta 2 (GBA2) or beta-glucosidase (GBA), those are well-defined enzymes with clear biological roles and drug interactions[1][2][8]. Pseudogenes, however, are not functional and therefore not direct drug targets, biomarkers, or disease agents. The "glucosidase beta 2 pseudogene" is a pseudogene, not a protein-coding gene, not an enzyme, and not a therapeutic target.